State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+4.87%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.9B
AUM Growth
+$692M
(+2%)
Cap. Flow
-$609M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,660
New
123
Increased
661
Reduced
730
Closed
128
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$183M |
| 2 |
HCA Healthcare
HCA
|
+$115M |
| 3 |
AGN
Allergan plc
AGN
|
+$108M |
| 4 |
Willis Towers Watson
WTW
|
+$103M |
| 5 |
Parker-Hannifin
PH
|
+$99.2M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$168M |
| 2 |
Apple
AAPL
|
+$89.4M |
| 3 |
Microsoft
MSFT
|
+$86.5M |
| 4 |
Johnson & Johnson
JNJ
|
+$79.1M |
| 5 |
JPMorgan Chase
JPM
|
+$68M |
Sector Composition
| 1 | Technology | 17.85% |
| 2 | Financials | 16.67% |
| 3 | Healthcare | 13.41% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Jefferies Financial Group
JEF
$13.7B
| $1.32M | ﹤0.01% |
76,646
-102,714
| -57% | -$1.77M |
|
1077
Apellis Pharmaceuticals
APLS
$3.14B
| $1.32M | ﹤0.01% |
52,000
+1,100
| +2% | +$27.9K |
|
|
SAGE
1078
DELISTED
Sage Therapeutics
SAGE
| $1.32M | ﹤0.01% |
7,198
-1,917
| -21% | -$351K |
|
1079
West Pharmaceutical
WST
$18.2B
| $1.31M | ﹤0.01% |
10,455
-3,199
| -23% | -$400K |
|
1080
Booz Allen Hamilton
BAH
$12.9B
| $1.29M | ﹤0.01% |
19,463
-6,172
| -24% | -$409K |
|
1081
Qiagen
QGEN
$9.82B
| $1.28M | ﹤0.01% |
29,785
-9,272
| -24% | -$399K |
|
1082
Essential Utilities
WTRG
$10.7B
| $1.28M | ﹤0.01% |
30,819
-2,464
| -7% | -$102K |
|
1083
Molina Healthcare
MOH
$9.8B
| $1.27M | ﹤0.01% |
8,890
-2,757
| -24% | -$395K |
|
1084
Fair Isaac
FICO
$37.1B
| $1.27M | ﹤0.01% |
4,048
-1,306
| -24% | -$410K |
|
|
AIMT
1085
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.27M | ﹤0.01% |
61,000
+1,300
| +2% | +$27.1K |
|
1086
Crawford & Co Class B
CRD.B
$494M
| $1.25M | ﹤0.01% |
134,152
+37,500
| +39% | +$349K |
|
1087
Natera
NTRA
$23.1B
| $1.24M | ﹤0.01% |
44,900
+1,000
| +2% | +$27.6K |
|
|
BKI
1088
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.24M | ﹤0.01% |
20,539
-5,998
| -23% | -$361K |
|
|
SPPI
1089
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.24M | ﹤0.01% |
143,400
+3,200
| +2% | +$27.6K |
|
1090
Trade Desk
TTD
$22.1B
| $1.23M | ﹤0.01% |
+54,090
| New | +$1.23M |
|
1091
Atara Biotherapeutics
ATRA
$85.1M
| $1.23M | ﹤0.01% |
2,436
+128
| +6% | +$64.4K |
|
|
INFN
1092
DELISTED
Infinera Corporation Common Stock
INFN
| $1.22M | ﹤0.01% |
+420,000
| New | +$1.22M |
|
1093
Amdocs
DOX
$9.35B
| $1.22M | ﹤0.01% |
19,602
-6,291
| -24% | -$391K |
|
1094
Euronet Worldwide
EEFT
$3.6B
| $1.2M | ﹤0.01% |
7,133
-2,090
| -23% | -$352K |
|
|
ATNX
1095
DELISTED
Athenex, Inc. Common Stock
ATNX
| $1.19M | ﹤0.01% |
3,010
+65
| +2% | +$25.7K |
|
|
DRNA
1096
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.19M | ﹤0.01% |
75,600
+1,700
| +2% | +$26.8K |
|
1097
Graco
GGG
$14B
| $1.18M | ﹤0.01% |
23,550
-7,341
| -24% | -$368K |
|
1098
Teradyne
TER
$17.9B
| $1.17M | ﹤0.01% |
24,384
-9,039
| -27% | -$433K |
|
1099
Tyler Technologies
TYL
$23.6B
| $1.16M | ﹤0.01% |
5,383
-1,769
| -25% | -$382K |
|
1100
Travere Therapeutics
TVTX
$2.09B
| $1.16M | ﹤0.01% |
57,800
+1,300
| +2% | +$26.1K |
|